Currently out of the existing stock ratings of Constantine Davides, 43 are a BUY (100%).

Constantine Davides

Work Performance Price Targets & Ratings Chart

Analyst Constantine Davides, currently employed at JMP, carries an average stock price target met ratio of 23.33% that have a potential upside of 42.51% achieved within 57 days. Previously, Constantine Davides worked at BENCHMARK.

Constantine Davides’s has documented 83 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on AGL, agilon health at 11-Nov-2024.

Wall Street Analyst Constantine Davides

Analyst best performing recommendations are on ISPC (ISPECIMEN).
The best stock recommendation documented was for ISPC (ISPECIMEN) at 11/23/2021. The price target of $12 was fulfilled within 1 day with a profit of $1.19 (9.02%) receiving and performance score of 90.22.

Average potential price target upside

ACER Acer Therapeutics BIVI Biovie ACST Acasti Pharma ELMD Electromed HCTI Healthcare Triangle HCWB HCW Biologics HOTH Hoth Therapeutics INVA Innoviva ISPC iSpecimen KTTA Pasithea Therapeutics Corp LGVN Longeveron LLC NMRD Nemaura Medical NNVC NanoViricides MEDS Trxade Group AGL agilon health AMN AMN Healthcare Services

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$1.5

$0.84 (127.27%)

$10

1 years 2 months 16 days ago
(01-Sep-2023)

0/3 (0%)

$0.36 (31.58%)

Buy

$8

$7.34 (1112.12%)

$9

2 years 8 months 10 days ago
(07-Mar-2022)

0/2 (0%)

$5.54 (225.20%)

Buy

$8

$7.34 (1112.12%)

$48

5 years 4 months 23 days ago
(25-Jun-2019)

0/4 (0%)

$3.88 (94.17%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Constantine Davides is most bullish on?

Potential upside of $33.3 has been obtained for AMN (AMN HEALTHCARE SERVICES)

Which stock is Constantine Davides is most reserved on?

Potential downside of -$0 has been obtained for AGL (AGILON HEALTH)

What Year was the first public recommendation made by Constantine Davides?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?